Clinical trial gives patient hope for tomorrow

November 18, 2026 Providence Oregon News Team

Above: Julie Gage gets her 200th infusion at Providence St. Vincent Medical Center. She receives an infusion every three weeks to help manage her stage IV breast cancer diagnosis.

November 2026

For more than a decade, Julie Gage has lived with stage IV breast cancer, measuring her time in three-week treatment intervals. Recently, she celebrated her 200th infusion, a milestone that represents much more than a number.

“It’s given me hope that there's a tomorrow,” she says.  “Because when you kind of live on the finish line of life, tomorrow becomes a little abstract.”

After her cancer returned and spread to her bones, Julie joined a clinical trial at her oncologist’s recommendation. The treatment she received has since become standard care for patients with stage IV breast cancer.

“Her participation has helped countless other women,” says Zheng Topp, M.D., an oncologist and hematologist at Providence St. Vincent Medical Center.

For Julie, that treatment has meant more time for moments she once thought might never come, including becoming a grandmother.

“If you had told me I would hold a grandbaby, I wouldn't have believed you. Now I've had the opportunity to hold three. And for that, thank you, thank you,” Julie says.

Related

Previous Article
Patient care coordinator relishes the joy of supporting families and babies
Patient care coordinator relishes the joy of supporting families and babies

For Maureen Hartung, even the busiest days are blessed when she gets to be part of helping a family right a...

Next Article
After More Than 50 Years, Vietnam Vet Finally Sleeps
After More Than 50 Years, Vietnam Vet Finally Sleeps